Icon
+91 94997 68112
Login Register

TRINTELLIX (nda204447)- (EQ 5MG BASE,EQ 10MG BASE,EQ 15MG BASE,EQ 20MG BASE)

VORTIOXETINE HYDROBROMIDE TAKEDA PHARMS USA
EQ 5MG BASE,EQ 10MG BASE,EQ 15MG BASE,EQ 20MG BASE
Yes No
2032-Sep-21 2018-Sep-30
None None
None No
TRINTELLIX is indicated for the treatment of major depressive disorder (MDD) in adults.
1 6 0
Total Other Developers 6
Drugs with Suitability No
EQ 5MG BASE ** ** Up - -
EQ 10MG BASE ** ** Up - -
EQ 15MG BASE ** ** - - -
EQ 20MG BASE ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.